Tryp Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Tryp Therapeutics's estimated annual revenue is currently $1.7M per year.
- Tryp Therapeutics's estimated revenue per employee is $131,154
- Tryp Therapeutics's total funding is $7.6M.
Employee Data
- Tryp Therapeutics has 13 Employees.
- Tryp Therapeutics grew their employee count by 8% last year.
Tryp Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Interim CEO, Tryp Therapeutics | Reveal Email/Phone |
2 | CEO & Group Managing Director | Reveal Email/Phone |
3 | VP, Drug Development | Reveal Email/Phone |
4 | Senior Director Program Management and Clinical Operations | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chairman | Reveal Email/Phone |
Tryp Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Tryp Therapeutics?
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs. Tryp's psilocybin-for-neuropsychiatric disorders, or PFNâ„¢, program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders.
keywords:N/A$7.6M
Total Funding
13
Number of Employees
$1.7M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tryp Therapeutics News
InvestorNewsBreaks Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Doses First Patient in Clinical Trial for Psilocybin-Assisted Therapy...
The pipeline guide reviews pipeline therapeutics for Fibromyalgia (Central Nervous ... Tryp Therapeutics Inc; Virios Therapeutics, Inc.
Tryp Therapeutics is a clinical-stage biotechnology company focused on developing psilocybin-related molecules, including TRP-8803, for the...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 13 | -32% | N/A |
#2 | $2M | 13 | -46% | N/A |
#3 | $1.4M | 14 | -30% | N/A |
#4 | $1.2M | 15 | -25% | $2M |
#5 | $1.2M | 15 | 15% | N/A |